Ke Xiao – Chairman
Ke Xiao is the executive VP and the board director of Chengdu Kanghong Pharmaceutical Group Co., Ltd. Chairman and legal representative of Chengdu Kanghong Technology industrial (Group) Co.,Ltd. He has successively held the posts of VP and marketing director of Chengdu Kanghong Pharmaceutical Group Co., Ltd. He received his B.Sc from University of San Francisco, and EMBA from CEIBS.
Doron is a seasoned executive of the Israeli high-tech industry serving as chairman ,director and advisor to variety of technology companies. Previously CEO of Elron Electronic Industries (Nasdaq: ELRNF and TASE) and until recently a director of Given Imaging (NASDAQ: GIVN) until it was sold to Covidian. Currently board member of IceCure and HBL Hadasit traded on TASE ,chairman of MST ,Sight DX and Magisto and advisor to verity of technology companies. Doron is also a director in none profit organizations (the Israeli board of electronics and software industries ,national science museum ,young entrepreneurs and DVI- dental volunteers for Israel).
Suzana Nahum Zilberberg
Over a decade of experience as senior manager in life science . Currently CEO of BioLight. Previously dealt with BD and M&As at TEVA Pharmaceuticals, including Vice President Asia and Pacific, in which role she led TEVA’s penetration of Japan and China.
Hao Xiaofeng is the CEO and board director of Chengdu Kanghong Pharmaceutical Group Co., Ltd. He had more than 30 years’ work experience in pharmaceutical industry. He received his B.Sc degree from China Pharmaceutical University.
Yin Jinqun is the VP of Chengdu Kanghong Pharmaceutical Group Co., Ltd in charge of marketing and sales. He had more than 20 years proven track record of sales work experience in pharmaceutical industry. Prior to joining Kanghong, he had worked in Xian Janssen Pharmaceutical Ltd. (a subsidiary of Johnson &Johnson) and Bayer etc. Mr. Yin graduated from Beijing International MBA (BIMBA) at Peking University.